Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults
Active, not recruiting
- Conditions
- Heart Rate in the General Public
- Registration Number
- NCT06696339
- Lead Sponsor
- PreemptiveAI, Inc
- Brief Summary
The goal of this clinical trial is to assess the accuracy of the PreemptiveAI SDK to measure heart rate for adults as compared to an FDA-approved ground truth device.
Participants will:
* Complete a demographics and health history survey
* Apply and wear ground truth equipment such as a pulse oximeter and ECG
* Measure their heart rate 8 times with 4 different smartphones using the PreemptiveAI SDK
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Adults with both normal and abnormal heart rates
Exclusion Criteria
- Under 18 years of age
- Unable to speak and read English
- Deemed not suitable to participate by Investigator due to cognitive impairment, acute illness, or serious physical or mental health condition
- Essential tremor in left or right hand
- Raynaud's disease
- Severe calluses on left or right index finger
- Unable to produce a heart rate measurement due to low signal quality during the training phase (i.e. low perfusion, unable to hold hand steady, etc)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart Rate Error At single site visit, measured across 8 repetitions within a 1-hour period Root mean square error of heart rate compared to ground truth device
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Paul Allen Institute for Artificial Intelligence
🇺🇸Seattle, Washington, United States